The Division of Oncology is dedicated to developing multidisciplinary and lifesaving treatments for people worldwide who are affected by cancer. At the forefront of ground breaking treatments for cancer, our faculty is involved in more than 100 clinical trials to develop diagnostic and therapeutic approaches to various types of cancer.
How a magnetized wire attracts tumor cells
Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.
D-limonene could offset dry mouth in cancer patients
A Stanford collaboration between clinical and basic science researchers has led to the identification of a compound that could improve the quality of life for head and neck cancer patients.
PET tracer predicts success of cancer ‘vaccine’
With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer immunotherapy will be effective or not, according to a new Stanford study.
Multigene tests for breast cancer on the rise
Tests to detect mutations in multiple genes are replacing BRCA-only analyses in women with breast cancer, according to a study by scientists at Stanford and several other institutions. Greater access to genetic counselors needed.
For ‘Project Lung,’ research gets personal
When James Spudich was diagnosed with lung cancer, researchers had a rare, and unexpected, opportunity to study healthy and diseased human tissue at an unprecedented level of detail.
Conferences and Workshops
Stanford Review of the 60th Annual American Society of Hematology Meeting 2019
Ritz-Carlton Hotel, Half Moon Bay, CA
New courses are added regularly— please check back often
Non-Stanford CME Courses of Interest
17th Multidisciplinary Management of Cancers: A Case-Based Approach
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.